Bofanglutide
Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Not Treated With Positive Airway Pressure (PAP) Therapy
Gan & Lee Pharmaceuticals · Phase 3 · Not yet recruiting · Enrollment 140
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| GZR18 injection | Obstructive Sleep Apnea (OSA) | n/r | n/r | n/r | n/r |
| Placebo | Obstructive Sleep Apnea (OSA) | n/r | n/r | n/r | n/r |